Skip to content

Safety evaluation and effect of food supplement containing dietary fiber from cassava on the alterations of physiological parameters in overweight female volunteers

Safety evaluation and effect of food supplement containing dietary fiber from cassava on the alterations of physiological parameters in overweight female volunteers

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20190521001
Enrollment
Unknown
Registered
2019-05-21
Start date
2019-02-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy conditions fasting blood sugar HbA1c lipid profile atherosclerosis index (AI)

Interventions

starch 3 g/day,dietary fiber from cassava 1.5 g/day,dietary fiber from cassava 3 g/day
Placebo,dietary fiber 1.5 g/day,dietary fiber 3 g/day

Sponsors

National Research Council of Thailand
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 60 Years

Inclusion criteria

Inclusion criteria: - Live in Khon Kaen, Thailand - Aged between 35-60 years old - Body mass index more than 23 - blood pressure less than 140/90 mmHg - Fastig plasma glucose less than 100 mg/dL -All volunteers should not use other nutraceutical compounds or herbs or drugs which influenced on the nervous system function and bone at least 3 months before participating in this study - On the day of the study, all volunteers felt well and refrain from drinking tea or coffee, or alcohol

Exclusion criteria

Exclusion criteria: • Cardiovascular disease • Respiratory disease • Neuropsychological disorders • Diabetes • Liver disease • Renal disease • Endocrine dysfunction • Autoimmune disease

Design outcomes

Primary

MeasureTime frame
Body mass index 4 weeks equipment

Secondary

MeasureTime frame
clinical chemistry 4 weeks clinical laboratory,Complete blood count 4 weeks clinical laboratory,Homeostasis Model Assessment Insulin Resistance (HOMA-IR) 4 weeks clinical laboratory,atherosclerosis index (AI) 4 weeks clinical laboratory,Roseburia Blautia, Eubacterium rectale and Faecalibacterium prausnitzii 4 weeks clinical laboratory,bifidobacteria spp and Lactobacilli spp 4 weeks clinical laboratory

Countries

Thailand

Contacts

Public ContactWipawee Thukhammee

Khon Kaen University

wipath@kku.ac.th+6643348394

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026